ATE297382T1 - 3-heterocyclyl propanohydroxamsäure-derivaten als pcp inhibitoren - Google Patents

3-heterocyclyl propanohydroxamsäure-derivaten als pcp inhibitoren

Info

Publication number: ATE297382T1
Authority: AT; Austria
Prior art keywords: heterocyclyl; acid derivatives; propanohydroxamic acid; pcp inhibitors; pcp
Prior art date: 2001-03-30

Application number

AT02707045T

Other languages

English (en)

Inventor

Paul Vincent Fish

Jackie Diane Kendall

Gavin Alistair Whitlock

Inc Pfizer

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-30

Filing date

2002-03-18

Publication date

2005-06-15

2002-03-18 Application filed by Pfizer filed Critical Pfizer

2005-06-15 Application granted granted Critical

2005-06-15 Publication of ATE297382T1 publication Critical patent/ATE297382T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
- C07D271/07—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Surgery (AREA)
Ophthalmology & Optometry (AREA)
Dermatology (AREA)
Pulmonology (AREA)
Gastroenterology & Hepatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)
Peptides Or Proteins (AREA)
Pyridine Compounds (AREA)

AT02707045T 2001-03-30 2002-03-18 3-heterocyclyl propanohydroxamsäure-derivaten als pcp inhibitoren ATE297382T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0108097.7A GB0108097D0 (en)	2001-03-30	2001-03-30	Compounds
PCT/IB2002/000817 WO2002079175A1 (en)	2001-03-30	2002-03-18	3-heterocyclylpropanohydroxamic acid pcp inhibitors

Publications (1)

Publication Number	Publication Date
ATE297382T1 true ATE297382T1 (de)	2005-06-15

Family

ID=9911979

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02707045T ATE297382T1 (de)	2001-03-30	2002-03-18	3-heterocyclyl propanohydroxamsäure-derivaten als pcp inhibitoren

Country Status (16)

Country	Link
EP (1)	EP1373231B1 (de)
JP (1)	JP2004524364A (de)
AP (1)	AP2002002464A0 (de)
AT (1)	ATE297382T1 (de)
BR (1)	BR0208500A (de)
CA (1)	CA2442483C (de)
DE (1)	DE60204552T2 (de)
ES (1)	ES2240703T3 (de)
GB (1)	GB0108097D0 (de)
GT (1)	GT200200055A (de)
MX (1)	MXPA03008849A (de)
PA (1)	PA8542301A1 (de)
PE (1)	PE20021104A1 (de)
TN (1)	TNSN02035A1 (de)
UY (1)	UY27231A1 (de)
WO (1)	WO2002079175A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2009097893A1 (en) *	2008-02-04	2009-08-13	Proyecto De Biomedicina Cima, S.L.	Methods for the treatment of cardiac disease associated to myocardial fibrosis using an inhibitor of pcp
SG11201605539SA (en)	2014-01-10	2016-08-30	Glaxosmithkline Ip No 2 Ltd	Hydroxy formamide derivatives and their use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CZ20012294A3 (cs) *	1998-12-22	2001-12-12	F. Hoffmann-La Roche Ag	Sulfonamidové hydroxamáty
CN1362951A (zh) *	1999-03-03	2002-08-07	宝洁公司	二杂－取代的金属蛋白酶抑制剂
GB9930570D0 (en) *	1999-12-23	2000-02-16	Pfizer Ltd	Therapy

2001
- 2001-03-30 GB GBGB0108097.7A patent/GB0108097D0/en not_active Ceased
2002
- 2002-03-18 AT AT02707045T patent/ATE297382T1/de not_active IP Right Cessation
- 2002-03-18 EP EP02707045A patent/EP1373231B1/de not_active Expired - Lifetime
- 2002-03-18 MX MXPA03008849A patent/MXPA03008849A/es active IP Right Grant
- 2002-03-18 DE DE60204552T patent/DE60204552T2/de not_active Expired - Fee Related
- 2002-03-18 ES ES02707045T patent/ES2240703T3/es not_active Expired - Lifetime
- 2002-03-18 JP JP2002577802A patent/JP2004524364A/ja not_active Ceased
- 2002-03-18 CA CA002442483A patent/CA2442483C/en not_active Expired - Fee Related
- 2002-03-18 WO PCT/IB2002/000817 patent/WO2002079175A1/en active IP Right Grant
- 2002-03-18 BR BR0208500-3A patent/BR0208500A/pt not_active IP Right Cessation
- 2002-03-21 GT GT200200055A patent/GT200200055A/es unknown
- 2002-03-27 PA PA20028542301A patent/PA8542301A1/es unknown
- 2002-03-27 UY UY27231A patent/UY27231A1/es not_active Application Discontinuation
- 2002-03-27 PE PE2002000250A patent/PE20021104A1/es not_active Application Discontinuation
- 2002-03-28 AP APAP/P/2002/002464A patent/AP2002002464A0/en unknown
- 2002-03-29 TN TNTNSN02035A patent/TNSN02035A1/fr unknown

Also Published As

Publication number	Publication date
DE60204552D1 (en)	2005-07-14
UY27231A1 (es)	2002-11-29
MXPA03008849A (es)	2003-12-11
TNSN02035A1 (fr)	2005-12-23
GB0108097D0 (en)	2001-05-23
GT200200055A (es)	2002-11-21
EP1373231B1 (de)	2005-06-08
AP2002002464A0 (en)	2002-06-30
ES2240703T3 (es)	2005-10-16
CA2442483C (en)	2007-11-13
WO2002079175A1 (en)	2002-10-10
PA8542301A1 (es)	2002-10-28
BR0208500A (pt)	2004-04-20
EP1373231A1 (de)	2004-01-02
JP2004524364A (ja)	2004-08-12
PE20021104A1 (es)	2002-12-07
CA2442483A1 (en)	2002-10-10
DE60204552T2 (de)	2006-05-11

Publication	Publication Date	Title
ATE437862T1 (de)	2009-08-15	Pyrimidin-5-onderivate als ldl-pla2 inhibitoren
ATE493406T1 (de)	2011-01-15	Hydantoinderivate als mmp-inhibitoren
DE60234125D1 (de)	2009-12-03	E inhibitoren
ATE256127T1 (de)	2003-12-15	Betacarbolinderivate als phosphodiesterase- inhibitoren
ATE441631T1 (de)	2009-09-15	Phenylpiperidinderivate als serotonin- wiederaufnahmehemmer
ATE443054T1 (de)	2009-10-15	Cyano-pyrrolidine als dpp-iv inhibitoren
ATE478870T1 (de)	2010-09-15	Spiroindolinpiperidinderivate
DK1556385T3 (da)	2010-06-14	Heterocyclocarboxamid-derivater
DK1551802T3 (da)	2010-03-15	Indol-3-svovlderivater
ATE467631T1 (de)	2010-05-15	Chinuclidinamidderivate
IS7720A (is)	2005-03-01	Píperidín-N-oxíð-afleiður
DE60315862D1 (de)	2007-10-04	Dihydropyridinonderivate als hne-inhibitoren
ATE438644T1 (de)	2009-08-15	Chinazolinderivate
DK2248807T3 (da)	2013-08-26	N-Phenyl-2-pyrimidinaminderivater
DE60106252D1 (de)	2004-11-11	Substituierte pyprolopyridinonderivate als phosphodiesterase-inhibitoren
ATE529428T1 (de)	2011-11-15	Thioxanthinderivate als myeloperoxidaseinhibitoren
NO20050665L (no)	2005-04-18	Pyrrolidonderivater som MAOE inhibitoere
NO20034032D0 (no)	2003-09-11	Metallproteinase-inhibitorer
DE60203529D1 (de)	2005-05-04	Indolderivate als cox-ii-inhibitoren
DE602004011548D1 (de)	2008-03-13	4-aminochinolin-3-carbonsäureamid-derivate als pde4-hemmer
ATE440821T1 (de)	2009-09-15	Isochinolinderivate als mao-b inhibitoren
ATE335729T1 (de)	2006-09-15	3h-chinazoline -4-on derivaten
DE60218213D1 (de)	2007-03-29	Pyridyloxyalkancarbonsäureamid-derivate verwendbar als fungizide
ATE308325T1 (de)	2005-11-15	Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trion derivate als metalloproteinase inhibitoren
ATE423771T1 (de)	2009-03-15	Tetrahydrochinolinderivate

Legal Events

Date	Code	Title	Description
2005-12-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties